Stockysis

Article

HC Wainwright & Co. Reiterates Buy on Protara Therapeutics, Maintains $23 Price Target

Benzinga Newsdesk | Feb 10, 2026 12:05 | Source: www.benzinga.com

HC Wainwright & Co. analyst Andres Y. Maldonado reiterates Protara Therapeutics (NASDAQ:TARA) with a Buy and maintains $23 price target.

Comments